Results 11 to 20 of about 282,918 (268)
Predictive biomarkers and clinical evidence [PDF]
AbstractPredictive biomarkers play an important role in our efforts to individualize pharmacotherapy, and within recent years, a number of different types of assays have been introduced. These biomarkers may potentially support the selection and dosage of specific drugs in order to maximize efficacy and minimize adverse reactions in the individual ...
openaire +2 more sources
Predictive biomarkers in gastric cancer [PDF]
AbstractPredictive biomarkers are the mainstay of precision medicine. This review summarizes the advancements in tissue-based diagnostic biomarkers for gastric cancer, which is considered the leading cause of cancer-related deaths worldwide. A disease seen in the elderly, it is often diagnosed at an advanced stage, thereby limiting therapeutic options.
openaire +2 more sources
Prognostic and Predictive Biomarkers in Gliomas [PDF]
Gliomas are the most common central nervous system tumors. New technologies, including genetic research and advanced statistical methods, revolutionize the therapeutic approach to the patient and reveal new points of treatment options. Moreover, the 2021 World Health Organization Classification of Tumors of the Central Nervous System has fundamentally ...
Paulina Śledzińska +4 more
openaire +2 more sources
Hepatocellular carcinoma (HCC) is the fifth most common malignancy and the third most common cause of cancer-related death worldwide. Due to asymptomatic patients in the early stage, most patients are diagnosed at an advanced stage and lose the ...
Penghui He +6 more
doaj +1 more source
Immune checkpoint inhibitors (ICI) have been applied in treating advanced hepatocellular carcinoma (aHCC) patients, but few patients exhibit stable and lasting responses. Moreover, identifying aHCC patients suitable for ICI treatment is still challenged.
Jan-Mou Lee +16 more
doaj +1 more source
Resistance to antibody‐drug conjugates in breast cancer: mechanisms and solutions
Antibody‐drug conjugates (ADCs) are a rapidly developing therapeutic approach in cancer treatment that has shown remarkable activity in breast cancer. Currently, there are two ADCs approved for the treatment of human epidermal growth factor receptor 2 ...
Yu‐Fei Chen +3 more
doaj +1 more source
On the quantitative assessment of predictive biomarkers [PDF]
Predictive biomarkers are among the most direct steps towards converting precision medicine into a clinical reality. By their very definition they are fundamentally different from prognostic or diagnostic biomarkers—instead of helping identify individuals who will develop the disease, they focus on differentiating between those who will and will not ...
Jason P, Fine, Michael, Pencina
openaire +2 more sources
BackgroundImmunotherapy is significantly revolutionizing cancer treatment and demonstrating promising efficacy in gastric cancer (GC) patients. However, only a subset of patients could derive benefits from targeted monoclonal antibody therapy against ...
Yidan Hou +5 more
doaj +1 more source
Serum Biomarkers for the Prediction of Hepatocellular Carcinoma [PDF]
Hepatocellular carcinoma (HCC) is a leading cause of global cancer death. Major etiologies of HCC relate to chronic viral infections as well as metabolic conditions. The survival rate of people with HCC is very low and has been attributed to late diagnosis with limited treatment options. Combining ultrasound and the biomarker alpha-fetoprotein (AFP) is
José D, Debes +6 more
openaire +4 more sources
BackgroundThe goal of this study was to identify potential predictive biomarkers for the therapeutic effect of infliximab (IFX) in Rheumatoid arthritis (RA) and explore the potential molecular mechanism of nonresponse to IFX treatment to achieve ...
Yongsong Cai +11 more
doaj +1 more source

